57 studies found for:    Alkermes
Show Display Options
Rank Status Study
21 Completed Study of Human Insulin Inhalation Powder in Patients With Type 2 Diabetes
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Human Insulin Inhalation Powder;   Drug: Injectable insulin
22 Completed Evaluate the Efficacy and Safety of Insulin Compared to Glargine in Patients With Type 2 Diabetes
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Human Insulin Inhalation Powder;   Drug: Insulin Glargine
23 Completed Evaluate the Efficacy and Safety of Insulin in Patients With Type 2 Diabetes
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Human Insulin Inhalation Powder;   Drug: Insulin Glargine
24 Completed Evaluate the Efficacy of Insulin Patients With Type 1 Diabetes
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: Human Insulin Inhalation Powder;   Drug: Injectable insulin;   Drug: Insulin Glargine
25 Completed Compare Two Dosing Algorithms in Insulin-Naive Patients With Type 2 Diabetes Mellitus
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: simplified diabetes regimen starting with a fixed dose of Human Insulin Inhalation Powder;   Drug: intensive diabetes management starting with an adjusted dose of Human Insulin Inhalation Powder
26 Completed
Has Results
ALK21-014: Efficacy and Safety of Medisorb® Naltrexone (VIVITROL®) After Enforced Abstinence
Condition: Alcohol Dependence
Interventions: Drug: VIVITROL 380 mg;   Drug: Placebo for VIVITROL 380 mg
27 Completed
Has Results
ALK21-003: Study of Medisorb® Naltrexone (VIVITROL®) in Alcohol-Dependent Adults
Condition: Alcoholism
Interventions: Drug: Medisorb naltrexone 190 mg;   Drug: Medisorb naltrexone 380 mg;   Drug: Placebo matching Medisorb naltrexone 190 mg;   Drug: Placebo matching Medisorb naltrexone 380 mg
28 Active, not recruiting A Study of VIVITROL in the Prevention of Re-arrest and Re-incarceration
Condition: Opioid Dependence
Intervention: Drug: VIVITROL 380mg
29 Completed
Has Results
ALK27-001: A Study of Trospium Inhalation Powder (TrIP)Administered to Subjects With COPD
Condition: Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Drug: Placebo;   Drug: TrIP-2D;   Drug: TrIP-2SS;   Drug: TrIP-2SS + Foradil
30 Completed
Has Results
ALK21-004: Single-dose Opiate Challenge of Medisorb® Naltrexone (VIVITROL®) in Adults Who Use Opioids
Condition: Opiate Dependence
Interventions: Drug: Medisorb naltrexone 75 mg;   Drug: Medisorb naltrexone 150 mg;   Drug: Medisorb naltrexone 300 mg;   Drug: Hydromorphone (10 mg/mL);   Drug: Naloxone Challenge and Oral Naltrexone Tolerability Testing
31 Completed
Has Results
ALK21-006: Long-Term Study of Medisorb® Naltrexone (VIVITROL®)
Condition: Alcoholism
Interventions: Drug: Medisorb naltrexone 380 mg;   Drug: Oral naltrexone 50 mg
32 Completed ALK33BUP-201: Safety and Tolerability Study of ALKS 33-BUP (ALKS 5461) Administration in Subjects With MDD
Condition: Major Depressive Disorder
Interventions: Drug: ALKS 5461;   Drug: Placebo
33 Completed The Safety and Effectiveness of RMP-7 Plus Amphotericin B in Patients With HIV and Cryptococcal Meningitis
Conditions: Meningitis, Cryptococcal;   HIV Infections
Interventions: Drug: Lobradimil;   Drug: Amphotericin B
34 Completed
Has Results
ALK21-013: Efficacy and Safety of Medisorb® Naltrexone (VIVITROL®) in Adults With Opioid Dependence
Condition: Opiate Dependence
Interventions: Drug: VIVITROL® 380 mg;   Drug: Placebo
35 Completed ALK33-001: A Study of RDC-0313 Administered to Healthy Adults
Condition: Alcohol Dependence
Interventions: Drug: RDC-0313;   Drug: Placebo
36 Terminated Efficacy, Safety and Tolerability Study of N1539 in Subjects After Abdominal Laparoscopic Surgery
Condition: Laparoscopic Surgery
Interventions: Drug: N1539;   Drug: Ketorolac Tromethamine;   Drug: Placebo
37 Completed ALK29-002: A Study of Baclofen Formulations in Healthy Adults
Condition: Alcohol Dependence
Interventions: Drug: Baclofen IR;   Drug: Baclofen ER
38 Completed
Has Results
ALK21-018: Effects of Medisorb® Naltrexone (VIVITROL®) on Alcohol Craving in Treatment-seeking, Alcohol-dependent Adults
Condition: Alcohol Dependence
Interventions: Drug: VIVITROL 380 mg;   Drug: Placebo
39 Active, not recruiting ALK21-025: Vivitrol's Cost and Treatment Outcomes Registry
Condition: Opioid Dependence
Intervention:
40 Completed Study to Evaluate the Efficacy, Safety and Tolerability of N1539
Condition: Hysterectomy
Interventions: Drug: N1539;   Drug: placebo;   Drug: Morphine

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-57) Show next page of results
Indicates status has not been verified in more than two years